亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

3D TAM

總結
A 3D-Printed Biomimetic Tumour Angiogenesis Model
技術優勢
A novel in-vitro-screening system for
prescreening of diagnostics and pharmaceuticals as well as testing drugs during tumour therapy
or analysis of tumour growth and tumour angiogenesis.
技術應用
The present invention allows for new strategies in the 3D-cell-printing of tumour models and an alternative to animal testing. On behalf of the University of Aachen, PROvendis is offering access for commercial use in terms of a license.
詳細技術說明
Despite major progress in finding alternative methods to animal use in drug discovery and development, laboratory animal testing is in many instances still inevitable. The law also requires animal testing to determine the safety and efficacy of new medicines before testing in humans. To reduce the number of experimental animals, several in-vitro-screening systems have been developed using different 3D-in-vitro-tissue-engineering approaches. However, even though significant progresses have been made, there is still no satisfying in-vitro-screening system available, which might represent a suitable alternative to animal studies.
合作類型
Licensing
申請日期
06/07/2015 00:00:00
申請號碼
PCx US 15/323,119
PCx EP 15 747 391.9
其他
No CN patents
ID號碼
3871
國家/地區
德國

欲了解更多信息,請點擊 這裡
移動設備